Hualan Biological EngineeringInc (002007) — Cash Flow Reinvestment Rate
Hualan Biological EngineeringInc (002007) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting CN¥36.14 Million (capex CN¥36.14 Million ) from operating cash flow of CN¥319.46 Million. See cash generation quality of Hualan Biological EngineeringInc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hualan Biological EngineeringInc Cash Flow Reinvestment Rate (2003–2024)
Historical reinvestment intensity for Hualan Biological EngineeringInc across 22 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Hualan Biological EngineeringInc.
Annual Cash Flow Reinvestment Rate for Hualan Biological EngineeringInc (2003–2024)
Year-by-year capital reinvestment analysis for Hualan Biological EngineeringInc. See 002007 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | CN¥599.21 Million | CN¥1.06 Billion | CN¥255.79 Million | ▼ -56.5% |
| 2023 | 1.30x | CN¥1.75 Billion | CN¥1.35 Billion | CN¥753.41 Million | ▼ -51.5% |
| 2022 | 2.68x | CN¥2.57 Billion | CN¥957.31 Million | CN¥393.95 Million | ▲ +103.8% |
| 2021 | 1.32x | CN¥1.89 Billion | CN¥1.43 Billion | CN¥811.35 Million | ▲ +106.5% |
| 2020 | 0.64x | CN¥845.31 Million | CN¥1.33 Billion | CN¥621.44 Million | ▲ +2.9% |
| 2019 | 0.62x | CN¥845.09 Million | CN¥1.36 Billion | CN¥272.95 Million | ▼ -14.4% |
| 2018 | 0.72x | CN¥936.97 Million | CN¥1.29 Billion | CN¥183.26 Million | ▲ +3.6% |
| 2017 | 0.70x | CN¥124.12 Million | CN¥177.42 Million | CN¥108.54 Million | ▼ -3.8% |
| 2016 | 0.73x | CN¥239.94 Million | CN¥329.94 Million | CN¥220.66 Million | ▼ -29.9% |
| 2015 | 1.04x | CN¥569.20 Million | CN¥548.62 Million | CN¥229.34 Million | ▲ +270.5% |
| 2014 | 0.28x | CN¥139.21 Million | CN¥497.15 Million | CN¥139.21 Million | ▼ -42.6% |
| 2013 | 0.49x | CN¥249.21 Million | CN¥510.70 Million | CN¥249.21 Million | ▲ +64.0% |
| 2012 | 0.30x | CN¥147.15 Million | CN¥494.69 Million | CN¥147.15 Million | ▼ -30.4% |
| 2011 | 0.43x | CN¥143.59 Million | CN¥335.93 Million | CN¥143.59 Million | ▲ +74.1% |
| 2010 | 0.25x | CN¥149.67 Million | CN¥609.53 Million | CN¥149.67 Million | ▼ -8.1% |
| 2009 | 0.27x | CN¥162.43 Million | CN¥607.73 Million | CN¥162.43 Million | ▼ -66.1% |
| 2008 | 0.79x | CN¥126.90 Million | CN¥161.18 Million | CN¥126.90 Million | ▼ -34.1% |
| 2007 | 1.19x | CN¥213.92 Million | CN¥179.02 Million | CN¥213.92 Million | ▼ -27.7% |
| 2006 | 1.65x | CN¥217.30 Million | CN¥131.43 Million | CN¥217.30 Million | ▲ +177.2% |
| 2005 | 0.60x | CN¥58.59 Million | CN¥98.24 Million | CN¥58.59 Million | ▼ -41.8% |
| 2004 | 1.02x | CN¥22.00 Million | CN¥21.48 Million | CN¥22.00 Million | ▼ -89.6% |
| 2003 | 9.81x | CN¥32.82 Million | CN¥3.35 Million | CN¥32.82 Million | — |